1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Preece, N.E. Nguyen, M. Mahata, M. Mahata, S.K. Mahapatra, N.R. Tsigelny, I. O'Connor, D.T. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking NE Regul.Pept. 0167-0115 118 75 87 10.1016/j.regpep.2003.10.035 14759560 Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A 2004 10.2210/pdb1n2y/pdb pdb_00001n2y 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 1662.961 CATESTATIN 1 syn polymer no no CFRARGYGFRGPGLC CFRARGYGFRGPGLC A polypeptide(L) n n n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2002-11-13 1 1 2008-04-28 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name 2002-11-13 SPRSDE SEQUENCE THE TERMINAL CYSTEINES ARE NON-NATIVE BUT WERE INCLUDED TO FACILITATE THE SYNTHESIS OF THE CYCLIC PEPTIDE. RCSB Y RCSB 2002-10-24 REL REL THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. SOLID PHASE SYNTHESIS AND FACILE CYCLIZATION OF TERMINAL CYSTEINES BY OXIDATION WAS PERFORMED. THE SEQUENCE OF THE PEPTIDE IS NATURALLY FOUND IN BOS TAURUS (COW). sample DMSO-D6 DOMINANT CLUSTER and outliers 20 12 2D NOESY DQF-COSY P-COSY BASHD-TOCSY 10 mM PHOSPHATE 7 AMBIENT 278 K RESTRAINED MOLECULAR DYNAMICS, CHEMICAL SHIFT REFINEMENT 8 4MG SS-CYCLIZED CATESTATIN 15-MER refinement X-PLOR structure solution VNMR structure solution Felix structure solution Discover structure solution X-PLOR 500 Varian UNITYPLUS 500 Varian INOVA CYS 1 n 1 CYS 1 A PHE 2 n 2 PHE 2 A ARG 3 n 3 ARG 3 A ALA 4 n 4 ALA 4 A ARG 5 n 5 ARG 5 A GLY 6 n 6 GLY 6 A TYR 7 n 7 TYR 7 A GLY 8 n 8 GLY 8 A PHE 9 n 9 PHE 9 A ARG 10 n 10 ARG 10 A GLY 11 n 11 GLY 11 A PRO 12 n 12 PRO 12 A GLY 13 n 13 GLY 13 A LEU 14 n 14 LEU 14 A CYS 15 n 15 CYS 15 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A N HA3 CYS GLY 1 11 1.24 1 A A H HA3 CYS GLY 1 11 1.33 1 A A H O PHE ARG 2 10 1.36 1 A A N CA CYS GLY 1 11 2.15 2 A A H H ARG GLY 5 6 0.99 2 A A O H ARG GLY 3 13 1.57 3 A A O HD2 PHE PRO 9 12 1.55 3 A A O N PHE GLY 9 11 2.14 4 A A O N ARG ARG 3 5 1.81 4 A A O N PHE GLY 9 11 2.15 5 A A O O ALA GLY 4 8 1.82 6 A A H O CYS LEU 1 14 1.50 6 A A O O ALA LEU 4 14 2.00 7 A A H H ARG GLY 5 6 1.07 7 A A O H GLY ARG 8 10 1.13 7 A A O H ARG GLY 3 13 1.34 7 A A O N GLY ARG 8 10 1.84 7 A A O N ARG GLY 3 13 2.15 8 A A O N ARG ARG 3 5 1.90 10 A A H O CYS ARG 1 3 1.59 10 A A O C ALA PHE 4 9 2.18 12 A A O HA CYS LEU 1 14 1.51 12 A A O O ARG ARG 3 10 1.71 1 A ARG 3 0.304 SIDE CHAIN 1 A ARG 5 0.280 SIDE CHAIN 1 A ARG 10 0.263 SIDE CHAIN 2 A ARG 3 0.206 SIDE CHAIN 2 A ARG 5 0.296 SIDE CHAIN 2 A ARG 10 0.311 SIDE CHAIN 3 A ARG 3 0.308 SIDE CHAIN 3 A ARG 5 0.316 SIDE CHAIN 3 A ARG 10 0.313 SIDE CHAIN 4 A ARG 3 0.189 SIDE CHAIN 4 A ARG 5 0.285 SIDE CHAIN 4 A ARG 10 0.302 SIDE CHAIN 5 A ARG 3 0.298 SIDE CHAIN 5 A ARG 5 0.247 SIDE CHAIN 5 A ARG 10 0.267 SIDE CHAIN 6 A ARG 3 0.148 SIDE CHAIN 6 A ARG 5 0.315 SIDE CHAIN 6 A ARG 10 0.249 SIDE CHAIN 7 A ARG 3 0.293 SIDE CHAIN 7 A ARG 5 0.266 SIDE CHAIN 7 A ARG 10 0.268 SIDE CHAIN 8 A ARG 3 0.327 SIDE CHAIN 8 A ARG 5 0.312 SIDE CHAIN 8 A ARG 10 0.224 SIDE CHAIN 9 A ARG 3 0.310 SIDE CHAIN 9 A ARG 5 0.229 SIDE CHAIN 9 A ARG 10 0.316 SIDE CHAIN 10 A ARG 3 0.311 SIDE CHAIN 10 A ARG 5 0.318 SIDE CHAIN 10 A ARG 10 0.306 SIDE CHAIN 11 A ARG 3 0.316 SIDE CHAIN 11 A ARG 5 0.223 SIDE CHAIN 11 A ARG 10 0.310 SIDE CHAIN 12 A ARG 3 0.289 SIDE CHAIN 12 A ARG 5 0.245 SIDE CHAIN 12 A ARG 10 0.306 SIDE CHAIN 1 -18.87 2.50 113.10 94.23 A A A N CA C GLY GLY GLY 6 6 6 N 2 -16.66 2.50 113.10 96.44 A A A N CA C GLY GLY GLY 6 6 6 N 2 9.44 1.50 119.30 128.74 A A A C N CA GLY PRO PRO 11 12 12 Y 2 -31.78 2.10 128.40 96.62 A A A C N CD GLY PRO PRO 11 12 12 Y 3 -18.18 2.50 113.10 94.92 A A A N CA C GLY GLY GLY 6 6 6 N 3 -16.09 2.50 113.10 97.01 A A A N CA C GLY GLY GLY 8 8 8 N 4 -16.86 2.70 111.00 94.14 A A A N CA C ARG ARG ARG 3 3 3 N 6 -19.30 2.70 111.00 91.70 A A A N CA C ARG ARG ARG 3 3 3 N 6 -21.63 2.10 128.40 106.77 A A A C N CD GLY PRO PRO 11 12 12 Y 7 -11.73 1.90 113.40 101.67 A A A CA CB CG TYR TYR TYR 7 7 7 N 7 -16.99 2.50 113.10 96.11 A A A N CA C GLY GLY GLY 8 8 8 N 8 -18.10 2.70 111.00 92.90 A A A N CA C ARG ARG ARG 3 3 3 N 8 -11.28 1.80 110.60 99.32 A A A N CA CB ARG ARG ARG 5 5 5 N 9 -13.39 1.80 110.60 97.21 A A A N CA CB ARG ARG ARG 10 10 10 N 9 -27.52 2.10 128.40 100.88 A A A C N CD GLY PRO PRO 11 12 12 Y 10 -18.42 2.70 111.00 92.58 A A A N CA C ARG ARG ARG 3 3 3 N 10 -19.67 2.70 111.00 91.33 A A A N CA C ALA ALA ALA 4 4 4 N 10 -18.96 2.50 113.10 94.14 A A A N CA C GLY GLY GLY 8 8 8 N 11 -15.11 2.50 113.10 97.99 A A A N CA C GLY GLY GLY 13 13 13 N 12 -10.91 1.40 110.10 99.19 A A A N CA CB ALA ALA ALA 4 4 4 N 12 -19.14 2.50 113.10 93.96 A A A N CA C GLY GLY GLY 6 6 6 N 12 -12.65 2.00 116.20 103.55 A A A CA C N TYR TYR GLY 7 7 8 Y 12 -16.05 2.50 113.10 97.05 A A A N CA C GLY GLY GLY 8 8 8 N 12 -10.74 1.40 111.70 100.96 A A A CA N CD PRO PRO PRO 12 12 12 N 1 A PHE 2 -127.46 -86.92 1 A TYR 7 -38.93 154.13 1 A PRO 12 35.96 -76.12 2 A ARG 3 -105.40 -67.89 2 A ARG 5 -162.84 -22.66 2 A ARG 10 -42.91 177.52 2 A PRO 12 -27.27 173.68 3 A ARG 3 -122.14 -68.09 3 A TYR 7 -44.24 87.09 3 A ARG 10 -28.95 85.23 3 A PRO 12 -41.43 -81.20 3 A LEU 14 -109.24 75.88 4 A PHE 2 -95.00 -67.56 4 A ALA 4 -23.23 71.94 4 A ARG 10 -41.93 81.58 4 A PRO 12 -76.18 -111.60 4 A LEU 14 -121.10 -73.33 5 A PHE 2 -126.18 -69.67 5 A ARG 3 -121.62 -63.19 5 A ARG 5 -81.96 44.00 5 A TYR 7 -124.36 -59.91 5 A PHE 9 -37.26 -32.08 5 A PRO 12 -60.53 -140.32 5 A LEU 14 -116.03 -124.57 6 A PHE 2 -81.47 -77.05 6 A ARG 3 -69.10 -104.95 6 A ARG 5 -169.57 -44.91 6 A TYR 7 -119.71 -70.90 6 A PHE 9 -19.51 70.37 6 A ARG 10 -131.96 -116.15 6 A PRO 12 51.04 -108.70 6 A LEU 14 -54.55 -166.93 7 A ARG 3 -106.17 -75.61 7 A ARG 5 -161.19 -9.54 7 A PHE 9 -23.85 42.76 7 A PRO 12 37.38 -87.62 7 A LEU 14 -99.92 59.11 8 A PHE 2 -128.42 -66.65 8 A ALA 4 -16.80 71.91 8 A ARG 10 -43.01 82.28 8 A PRO 12 -65.18 -138.82 8 A LEU 14 -116.49 -152.42 9 A PHE 2 -124.58 -83.41 9 A ARG 3 -107.62 -74.88 9 A ALA 4 -142.40 38.72 9 A ARG 5 -152.69 5.11 9 A ARG 10 -38.92 -179.33 9 A PRO 12 -90.59 -74.26 10 A PHE 2 -65.88 -77.72 10 A ARG 3 -84.10 -79.86 10 A ALA 4 -145.99 59.46 10 A ARG 5 -145.90 25.90 10 A TYR 7 -121.32 -129.55 10 A PHE 9 -36.94 -75.40 10 A PRO 12 -46.89 -104.03 11 A PHE 2 -94.07 -102.95 11 A ARG 3 -74.21 -73.77 11 A ARG 5 -83.46 40.13 11 A PHE 9 -116.06 78.95 11 A ARG 10 -43.95 99.75 11 A PRO 12 -9.42 -51.56 11 A LEU 14 -53.30 -163.73 12 A PHE 2 -39.26 -142.82 12 A TYR 7 -56.95 179.87 12 A PHE 9 -141.51 43.20 12 A ARG 10 -69.55 54.31 12 A PRO 12 -16.79 -70.50 SOLUTION STRUCTURE OF SS-CYCLIZED CATESTATIN FRAGMENT FROM CHROMOGRANIN A 1 N N disulf 2.035 A CYS 1 A SG CYS 1 1_555 A CYS 15 A SG CYS 15 1_555 SIGNALING PROTEIN CATESTATIN CHOROMOGRANIN A, SIGNALING PROTEIN CMGA_BOVIN UNP 1 368 P05059 FRARGYGFRGPGL 368 380 1N2Y 2 14 P05059 A 1 2 14 1 SEE REMARK 999 CYS 1 1N2Y A P05059 UNP 1 1 SEE REMARK 999 CYS 15 1N2Y A P05059 UNP 15 1 P 1